Skip to Content

Barrett’s and Esophageal Adenocarcinoma Consortium (BEACON)

The International Barrett’s and Esophageal Adenocarcinoma Consortium (BEACON) was set-up in 2005 with support from the National Cancer Institute. BEACON is composed of over three dozen investigators with completed or ongoing epidemiologic studies of esophageal adenocarcinoma and/or Barrett’s esophagus. This open scientific forum now has more than 50 members who have research interests in the etiology and prevention of these diseases. The current chair is Dr. Thomas L. Vaughan, a Professor of Epidemiology at the Fred Hutchinson Cancer Research Center. 

Analyses from the BEACON group so far have included reproductive factors (Eur J Cancer 2010), cigarette smoking (J Natl Cancer Inst 2010, Gastroenterology 2012), alcohol consumption (Gut 2011), non-steroidal anti-inflammatory drugs (Gastroenterology 2012), excess risk models (Cancer Epidemiol 2012), anthropometry (Int J Epidemiol 2012, (Gut 2013), and genome-wide analyses for susceptibility loci (Nat Genet 2013, J Natl Cancer Inst 2013) in relation to Barrett’s esophagus and/or adenocarcinomas of the esophagus.

For more information, contact Michael Cook.